Stock 4548 SEIKAGAKU CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Seikagaku Corporation

Equities

4548

JP3414000004

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
737 JPY 0.00% Intraday chart for Seikagaku Corporation -0.41% -3.15%
Apr. 08 Ferring Pharmaceuticals Inc. Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024 CI
2023 Seikagaku Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI

Business Summary

SEIKAGAKU CORPORATION is principally engaged in the research, development, purchase, manufacture and sale of pharmaceutical products and limulus amebocyte lysate (LAL). The Company operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic operation boosters and submucosal injection materials for endoscopes, as well as drug substances for various pharmaceuticals. The LAL business segment provides reagents for measuring endotoxin.

Number of employees: 976

Sales per Business

JPY in Million2022Weight2023Weight Delta
Drug
67.9 %
25,696 73.7 % 22,723 67.9 % -11.57%
Limulus Amebocyte Lysate
32.1 %
9,155 26.3 % 10,732 32.1 % +17.23%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
40.1 %
16,933 48.6 % 13,408 40.1 % -20.82%
North America
39.5 %
11,512 33.0 % 13,204 39.5 % +14.70%
Other Regions
20.5 %
6,405 18.4 % 6,844 20.5 % +6.85%

Managers

Managers TitleAgeSince
Ken Mizutani PSD
 President 76 88-07-31
Takayuki Akita ADM
 Chief Administrative Officer 60 17-05-31
Yosuke Funakoshi CTO
 Chief Tech/Sci/R&D Officer 58 14-07-31
Toshiyuki Okada BRD
 Director/Board Member 63 15-08-31
Atsushi Hariu IRC
 Investor Relations Contact - -
Daisuke Sugiyama AUD
 Comptroller/Controller/Auditor - -
Hiroyuki Konishi HRO
 Human Resources Officer - -
Susumu Ito PRN
 Corporate Officer/Principal - -
Shigeru Kawahara AUD
 Comptroller/Controller/Auditor 64 08-04-30
Toru Takeda AUD
 Comptroller/Controller/Auditor 64 16-03-31

Members of the board

Members of the board TitleAgeSince
Ken Mizutani PSD
 President 76 88-07-31
Eiji Katayama BRD
 Director/Board Member 73 97-05-31
Toshiyuki Okada BRD
 Director/Board Member 63 15-08-31
Yosuke Funakoshi CTO
 Chief Tech/Sci/R&D Officer 58 14-07-31
Takayuki Akita ADM
 Chief Administrative Officer 60 17-05-31
Mio Minaki BRD
 Director/Board Member 51 19-06-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 56,814,093 35,154,373 ( 61.88 %) 2,253,719 ( 3.967 %) 61.88 %

Shareholders

NameEquities%Valuation
Shingyo KK
13.81 %
7,843,460 13.81 % 40 M ¥
Kaiseisha KK
12.84 %
7,293,000 12.84 % 37 M ¥
Invesco Asset Management (Japan) Ltd.
9.278 %
5,271,200 9.278 % 27 M ¥
SEIKAGAKU CORPORATION
3.967 %
2,253,600 3.967 % 11 M ¥
Mizuho Bank Pension Fund
2.769 %
1,573,000 2.769 % 8 M ¥
MITSUBISHI UFJ FINANCIAL GROUP, INC
2.704 %
1,536,000 2.704 % 8 M ¥
KAKEN PHARMACEUTICAL CO., LTD.
2.124 %
1,207,000 2.124 % 6 M ¥
Mizutani Foundation for Glycoscience
1.457 %
828,000 1.457 % 4 M ¥
Meiji Yasuda Life Insurance Co.
1.211 %
688,000 1.211 % 3 M ¥
MIZUHO LEASING COMPANY, LIMITED
1.038 %
589,968 1.038 % 3 M ¥

Holdings

NameEquities%Valuation
KAKEN PHARMACEUTICAL CO., LTD.
1.09%
 502,500 1.09% 11,484,673 $
SANTEN PHARMACEUTICAL CO., LTD.
0.31%
 1,130,000 0.31% 11,472,099 $
SEIKAGAKU CORPORATION
3.97%
 2,253,600 3.97% 11,391,227 $
MIZUHO LEASING COMPANY, LIMITED
0.27%
 665,000 0.27% 5,105,750 $
MARUZEN SHOWA UNYU CO., LTD.
0.59%
 121,400 0.59% 3,754,019 $
MITSUBISHI UFJ FINANCIAL GROUP, INC
0.00%
 259,700 0.00% 2,671,729 $
TECHNO RYOWA LTD.
0.21%
 49,170 0.21% 658,871 $
MIZUHO FINANCIAL GROUP, INC.
0.00%
 24,040 0.00% 483,834 $
MEBUKI FINANCIAL GROUP,INC.
0.01%
 63,180 0.01% 213,571 $
DAI-ICHI LIFE HOLDINGS, INC.
0.00%
 3,700 0.00% 94,196 $

Company contact information

Seikagaku Corp.

Marunouchi Center Building, 10/F 1-6-1 Marunouchi

100-0005, Tokyo

+

http://www.seikagaku.co.jp
address Seikagaku Corporation(4548)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Seikagaku Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
737 JPY
Average target price
800 JPY
Spread / Average Target
+8.55%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SEIKAGAKU CORPORATION Stock Seikagaku Corporation
-3.15% 255M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.87% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.41% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.55% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.66% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.28% 231B
NOVARTIS AG Stock Novartis AG
+5.16% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-8.92% 195B
AMGEN INC. Stock Amgen Inc.
-5.10% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4548 Stock
  4. Company Seikagaku Corporation